Skip to main content

Medicare LCD list by contractor, page 3 of 5

This page continues the contractor-grouped list of all 851 active Local Coverage Determinations in the Medicare Coverage Database export of November 12, 2026, which starts on the LCD hub. It lists 207 policies from Novitas Solutions, Inc., Palmetto GBA: 91 link to a full reference page and 116 are listed as text, and 176 of them have a billing and coding article with covered ICD-10-CM codes.

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: Medicare Coverage Database LCD export: MCD release November 12, 2026 (effective November 8, 2026); Medicare Coverage Database billing and coding articles: MCD release November 12, 2026 (effective November 8, 2026). Next CMS release: weekly, every Thursday.

Policies on this page

Novitas Solutions, Inc. (continued) 71 policies · 12 states

Show 18 other Novitas Solutions, Inc. policies on this page (pages not in search results)
  • L34998 Transcranial Magnetic Stimulation (TMS) in the Treatment of Adults with Major Depressive Disorder
  • L35003 Intraoperative Neurophysiological Testing
  • L35014 Frequency of Hemodialysis
  • L35081 Nerve Conduction Studies and Electromyography
  • L35090 Cosmetic and Reconstructive Surgery
  • L35091 Cataract Extraction (including Complex Cataract Surgery)
  • L35125 Wound Care
  • L35130 Percutaneous Vertebral Augmentation (PVA) for Vertebral Compression Fracture (VCF)
  • L37371 Electroretinography (ERG)
  • L38223 Micro-Invasive Glaucoma Surgery (MIGS)
  • L38385 Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep Apnea
  • L38617 Implantable Continuous Glucose Monitors (I-CGM)
  • L38712 Transurethral Waterjet Ablation of the Prostate
  • L38807 Colon Capsule Endoscopy (CCE)
  • L39063 Pharmacogenomics Testing
  • L39068 Platelet Rich Plasma
  • L39793 Cervical Fusion
  • L39879 Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound

Palmetto GBA 187 policies · 18 states · continues on the next page

Show 98 other Palmetto GBA policies on this page (pages not in search results)
  • L33420 Lab: Bladder/Urothelial Tumor Markers
  • L33428 Cosmetic and Reconstructive Surgery
  • L33431 HbA1c
  • L33436 Mohs Micrographic Surgery (MMS)
  • L33455 Wireless Gastrointestinal Motility Monitoring Systems
  • L33456 Total Joint Arthroplasty
  • L34410 B-type Natriuretic Peptide (BNP) Testing
  • L34411 Blepharoplasty, Eyelid Surgery, and Brow Lift
  • L34413 Cataract Surgery
  • L34417 CT of the Head
  • L34424 Magnetic Resonance Angiography
  • L34431 Scanning Computerized Ophthalmic Diagnostic Imaging (SCODI)
  • L34433 Somatosensory Testing
  • L34434 Upper Gastrointestinal Endoscopy and Visualization
  • L34512 Corneal Pachymetry
  • L34513 Lab: Flow Cytometry
  • L34554 In Vitro Chemosensitivity & Chemoresistance Assays
  • L34565 Home Health-Surface Electrical Stimulation in the Treatment of Dysphagia
  • L34570 Psychiatric Inpatient Hospitalization
  • L34575 Frequency of Hemodialysis
  • L34578 Surface Electrical Stimulation in the Treatment of Dysphagia
  • L35048 Nerve Conduction Studies and Electromyography
  • L35073 MolDX: NRAS Genetic Testing
  • L35922 Lab: Special Histochemical Stains and Immunohistochemical Stains
  • L35974 MolDX: MGMT Promoter Methylation Analysis
  • L36125 MolDX: Breast Cancer Assay: Prosigna®
  • L36129 MolDX: Biomarkers in Cardiovascular Risk Assessment
  • L36427 Wireless Capsule Endoscopy
  • L36464 MolDX: HLA-DQB1*06:02 Testing for Narcolepsy
  • L36665 ProMark® Risk Score
  • L36761 GlycoMark® Testing for Glycemic Control
  • L36912 MolDX: Oncotype DX® Breast Cancer for DCIS (Genomic Health™)
  • L37022 Lab: Coenzyme Q10 (CoQ10)
  • L37031 BDX-XL2
  • L37033 MolDX: DecisionDx-UM (Uveal Melanoma)
  • L37260 MolDX: Prometheus® IBD sgi Diagnostic® Policy
  • L37264 MolDX: EndoPredict Breast Cancer Gene Expression Test
  • L37531 Micro-Invasive Glaucoma Surgery (MIGS)
  • L37581 Lab: Cystatin C Measurement
  • L37602 MDS FISH
  • L37632 Spinal Cord Stimulators for Chronic Pain
  • L37643 Routine Foot Care
  • L37644 YAG Capsulotomy
  • L37725 MolDX: Melanoma Risk Stratification Molecular Testing
  • L37826 Lumbar Artificial Disc Replacement
  • L37857 MolDX: Envisia™, Veracyte™, Idiopathic Pulmonary Fibrosis Diagnostic Test
  • L37863 Voretigene Neparvovec-rzyl (Luxturna®)
  • L37870 MolDX: Inivata™, InVisionFirst®, Liquid Biopsy for Patients with Lung Cancer
  • L38026 Corneal Hysteresis
  • L38045 MolDX: Next-Generation Sequencing for Solid Tumors
  • L38047 MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies
  • L38051 MolDX: Pigmented Lesion Assay
  • L38238 MolDX: Predictive Classifiers for Early Stage Non-Small Cell Lung Cancer
  • L38240 MolDX: Blood Product Molecular Antigen Typing
  • L38274 MolDX: Repeat Germline Testing
  • L38278 Non-Invasive Fractional Flow Reserve (FFR) for Ischemic Heart Disease
  • L38292 MolDX: Prostate Cancer Genomic Classifier Assay for Men with Localized Disease
  • L38294 MolDX: Pharmacogenomics Testing
  • L38549 Transurethral Waterjet Ablation of the Prostate
  • L38551 Transanal Endoscopic Surgery (TES)
  • L38576 MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer
  • L38737 Percutaneous Vertebral Augmentation (PVA) for Vertebral Compression Fracture (VCF)
  • L38743 Implantable Continuous Glucose Monitors (I-CGM)
  • L38745 Platelet Rich Plasma
  • L38755 Colon Capsule Endoscopy (CCE)
  • L38769 Computed Tomography Cerebral Perfusion Analysis (CTP)
  • L38775 Extracorporeal Shock Wave Therapy (ESWT)
  • L38786 Echocardiography for Myocardial Perfusion
  • L38792 Dexamethasone Intracanalicular Ophthalmic Insert (Dextenza®)
  • L38966 MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer
  • L38985 MolDX: Molecular Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer
  • L38988 MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing
  • L38994 Epidural Steroid Injections for Pain Management
  • L39086 Treatment of Males with Low Testosterone
  • L39121 Treatment of Varicose Veins of the Lower Extremities
  • L39128 Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
  • L39256 MolDX: Molecular Testing for Detection of Upper Gastrointestinal Metaplasia, Dysplasia, and Neoplasia
  • L39258 Surgical Treatment of Nails
  • L39270 Allogeneic Hematopoietic Cell Transplantation for Primary Refractory or Relapsed Hodgkin's and Non-Hodgkin's Lymphoma with B-cell or T-cell Origin
  • L39345 MolDX: Molecular Assays for the Diagnosis of Cutaneous Melanoma
  • L39385 Near-Infrared Spectroscopy in Wound and Flap Management
  • L39391 Vitamin D Assay Testing
  • L39402 Sacroiliac Joint Injections and Procedures
  • L39420 Thermal Destruction of the Intraosseous Basivertebral Nerve (BVN) for Vertebrogenic Lower Back Pain
  • L39424 MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis
  • L39573 Scalp Cooling for the Prevention of Chemotherapy-Induced Alopecia
  • L39583 MolDX: Molecular Biomarker Testing for Risk Stratification of Cutaneous Squamous Cell Carcinoma
  • L39636 MolDX: Gene Expression Profile Tests for Decision-Making in Castration Resistant and Metastatic Prostate Cancers
  • L39646 MolDX: Molecular Testing for Risk Stratification of Thyroid Nodules
  • L39654 MolDX: Molecular Biomarkers for Risk Stratification of Indeterminate Pulmonary Nodules Following Bronchoscopy
  • L39773 Cervical Fusion
  • L39797 Minimally Invasive Arthrodesis of the Sacroiliac Joint (SIJ)
  • L39836 Botulinum Toxin Injections
  • L39851 Artificial Intelligence Enabled CT Based Quantitative Coronary Topography (AI-QCT)/Coronary Plaque Analysis (AI-CPA)
  • L39919 MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms
  • L39933 MolDX: Genetic Testing for Heritable Thoracic Aortic Disease
  • L39935 MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis
  • L39942 Intervertebral Disc Repair

How the list is ordered

Each active policy appears once, under the first Medicare Administrative Contractor hub that lists it, in the order of the contractor hubs; policies that no A/B contractor hub lists, which are the durable medical equipment, home health and hospice policies, close the list. Inside a contractor, the policies with a full reference page come first, ordered by how often people search for the policy number, and the contractor's other policies follow as text in policy-number order. A contractor whose policies run across a page break is marked as continued, and the contractor hub always lists every active policy in that jurisdiction on one page.

Reading a local coverage policy

A Local Coverage Determination applies only to claims processed by the contractor that wrote it, so start from the contractor for the state where the service is furnished, or from the durable medical equipment contractor region for supplies and equipment. Then check the date of service against the policy's revision date: a revision that adds or removes diagnosis codes changes which claims pass the edit from that date forward.

The policy text sets out the covered indications, limitations and documentation requirements. Since January 2019 the procedure and diagnosis codes have lived in a companion billing and coding article, which is what the contractor loads as the claims edit; each policy page here shows the article's covered-code count with a sample and opens the full covered and non-covered lists. A policy listed as text on this page still has its own page with the same data; it is kept out of search results because it is another contractor's version of a title that its topic comparison covers, or a short policy with little search demand.

Other ways to find a policy

The LCD code lookup answers the question for one procedure code, one state and one diagnosis. The LCD lookup guide explains contractor jurisdictions and the appeal path, the NCD guide explains when a national policy overrides a local one, and the LCD coverage variation report shows how far the versions of a shared title differ between contractors. The topic list on the hub links every title that several contractors publish.

For teams evaluating QuickIntell software

Where QuickIntell fits with this policy

If your team repeatedly reviews local coverage policies, explore QuickAuth for requirement checks, documentation and status tracking with staff oversight. Confirm the applicable policy, supported workflow and review responsibilities. Use QuickRCM to evaluate the separate claim and denial workflow.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

Policy metadata and code counts are reproduced from the CMS Medicare Coverage Database export as an operational reference. Verify against the current LCD and article on cms.gov before billing. This continuation page is kept out of search results; the LCD hub and each policy's own page are the pages meant to be found. Not legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.